1.65 score from hupso.pl for:
one-ventures.com.au



HTML Content


Title oneventures - investment and venture capital

Length: 49, Words: 6
Description pusty

Length: 0, Words: 0
Keywords pusty
Robots index,follow
Charset UTF-8
Og Meta - Title pusty
Og Meta - Description pusty
Og Meta - Site name pusty
Tytuł powinien zawierać pomiędzy 10 a 70 znaków (ze spacjami), a mniej niż 12 słów w długości.
Meta opis powinien zawierać pomiędzy 50 a 160 znaków (łącznie ze spacjami), a mniej niż 24 słów w długości.
Kodowanie znaków powinny być określone , UTF-8 jest chyba najlepszy zestaw znaków, aby przejść z powodu UTF-8 jest bardziej międzynarodowy kodowaniem.
Otwarte obiekty wykresu powinny być obecne w stronie internetowej (więcej informacji na temat protokołu OpenGraph: http://ogp.me/)

SEO Content

Words/Characters 1589
Text/HTML 16.54 %
Headings H1 1
H2 14
H3 19
H4 5
H5 0
H6 0
H1
H2
investment with purpose
about oneventures
the oneventures team
funds
investment portfolio
awards and accolades
latest news
qld’s largest startup hub to drive innovation and generate jobs
qld’s largest startup hub to drive innovation and generate jobs
find-me technologies strengthens the board in readiness for rapid growth
oneventures awarded biomedical translation $170m funding
data published in cancer medicine demostrate clinical genomics' blood test for colorectal cancer recurrence is two-fold more sensitive than cea test
clinical genomics strenghtens it's leadership team with multiple key appointments
contact us
H3
connect with us
board of directors

oneventures healthcare fund iii
innovation and growth fund fund ii

oneventures innovation fund (fund i)
oneventures innovation fund (fund i)
oneventures innovation and growth fund (fund ii)
other investments
smart sparrow
vaxxas
incoming media
incoming media
smart sparrow
vaxxas
for entrepreneurs
for investors
general enquiries
H4 see all awards
see all news
sydney
brisbane
melbourne
H5
H6
strong
investment with purpose  
dr michelle deaker
dr paul kelly
anne-marie birkill
graeme wald
dr amir zalcenstein
james mcgrath
helen liu
jelly jakob
jen ball
walter lewin
simon moore
roger massy-greene

series a and beyond
b
i
em
Bolds strong 15
b 0
i 0
em 0
Zawartość strony internetowej powinno zawierać więcej niż 250 słów, z stopa tekst / kod jest wyższy niż 20%.
Pozycji używać znaczników (h1, h2, h3, ...), aby określić temat sekcji lub ustępów na stronie, ale zwykle, użyj mniej niż 6 dla każdego tagu pozycje zachować swoją stronę zwięzły.
Styl używać silnych i kursywy znaczniki podkreślić swoje słowa kluczowe swojej stronie, ale nie nadużywać (mniej niż 16 silnych tagi i 16 znaczników kursywy)

Statystyki strony

twitter:title pusty
twitter:description pusty
google+ itemprop=name pusty
Pliki zewnętrzne 14
Pliki CSS 1
Pliki javascript 13
Plik należy zmniejszyć całkowite odwołanie plików (CSS + JavaScript) do 7-8 maksymalnie.

Linki wewnętrzne i zewnętrzne

Linki 87
Linki wewnętrzne 79
Linki zewnętrzne 8
Linki bez atrybutu Title 24
Linki z atrybutem NOFOLLOW 0
Linki - Użyj atrybutu tytuł dla każdego łącza. Nofollow link jest link, który nie pozwala wyszukiwarkom boty zrealizują są odnośniki no follow. Należy zwracać uwagę na ich użytkowania

Linki wewnętrzne

about us #aboutus
team #team
funds #funds
portfolio #portfolio
awards #awards
news #news
contact us #contactus
about us #aboutus
team #team
funds #funds
portfolio #portfolio
awards #awards
news #news
contact us #contactus
- /team/#mdeaker
- /team/#pkelly
- /team/#abirkill
- /team/#gwald
- /team/#azalcenstein
- /team/#jmcgrath
- /team/#hliu
- /team/#jjakob
- /team/
- /team/#wlewin
- /team/#smoore
- /team/#rmgreene
- /portfolio/#hatchtech
- /portfolio/#vaxxas
- /portfolio/#smartsparrow
- /portfolio/#palomamobile
- /portfolio/#buildingiq
- /portfolio/#incomingmedia
- /portfolio/#charmhealth
- /portfolio/#peak3
- /portfolio/#beasy
- /portfolio/#findme
- /portfolio/#clinicalgenomics
- /portfolio/#vaxxas-fundii
- /portfolio/#employmenthero
- /portfolio/#agamatrix
- /awards/
smart sparrow /portfolio/#smartsparrow
finalist in the bill and melinda gates foundation $20m digital courseware challenge /news-story/2014/10/02/smart-sparrow-wins-gates-e-learning-grant/
vaxxas /portfolio/#vaxxas
world economic forum technology pioneer 2015 /news-story/2014/08/28/vaxxas-selected-as-world-economic-forum-technology-pioneer-2015/
incoming media /portfolio/#incomingmedia
warner bros announces 2014 media camp class /news-story/2014/06/02/warner-bros.-entertainment-announces-2014-media-camp-class/
incoming media /portfolio/#incomingmedia
spiffy award nominee 2013 - ground breaking award for engineering /news-story/2013/07/24/2013-spiffy-award-nominees-announced---nominee-roster-catalogs-the-telecom-startup-watch-list/
smart sparrow /portfolio/#smartsparrow
vaxxas /portfolio/#vaxxas
see all awards /awards/
qld’s largest startup hub to drive innovation and generate jobs news-story/2017/03/28/qld-s-largest-startup-hub-to-drive-innovation-and-generate-jobs
full story news-story/2017/03/28/qld-s-largest-startup-hub-to-drive-innovation-and-generate-jobs
qld’s largest startup hub to drive innovation and generate jobs news-story/2017/03/28/qld-s-largest-startup-hub-to-drive-innovation-and-generate-jobs
full story news-story/2017/03/28/qld-s-largest-startup-hub-to-drive-innovation-and-generate-jobs
find-me technologies strengthens the board in readiness for rapid growth news-story/2017/02/20/find-me-technologies-strengthens-the-board-in-readiness-for-rapid-growth
full story news-story/2017/02/20/find-me-technologies-strengthens-the-board-in-readiness-for-rapid-growth
oneventures awarded biomedical translation $170m funding news-story/2016/12/14/oneventures-awarded-biomedical-translation-$170m-funding
full story news-story/2016/12/14/oneventures-awarded-biomedical-translation-$170m-funding
data published in cancer medicine demostrate clinical genomics' blood test for colorectal cancer recurrence is two-fold more sensitive than cea test news-story/2016/10/19/data-published-in-cancer-medicine-demostrate-clinical-genomics'-blood-test-for-colorectal-cancer-recurrence-is-two-fold-more-sensitive-than-cea-test
full story news-story/2016/10/19/data-published-in-cancer-medicine-demostrate-clinical-genomics'-blood-test-for-colorectal-cancer-recurrence-is-two-fold-more-sensitive-than-cea-test
clinical genomics strenghtens it's leadership team with multiple key appointments news-story/2016/10/19/clinical-genomics-strenghtens-it's-leadership-team-with-multiple-key-appointments
full story news-story/2016/10/19/clinical-genomics-strenghtens-it's-leadership-team-with-multiple-key-appointments
see all news /news/
entrepreneurs@one-ventures.com mailto:entrepreneurs@one-ventures.com
back to the top #pagetop
disclaimer /disclaimer/
contact us /contact-us/

Linki zewnętrzne

- http://sb.co/programs/australia/
- http://headsoverheels.com.au/
- http://www.ilabaccelerator.com/
- https://investor.one-ventures.com/default.aspx
- http://linkedin.com/groups/oneventures-4458377?goback=.gan_4458377
global impact learning awards 2013 (silver) http://www.one-ventures.com.au/news-story/2013/07/18/smart-sparrow-wins-silver-at-learning-impact-2013-san-diego/
biospectrum emerging company of the year 2012 http://www.vaxxas.com/news/vaxxas-recognised-as-2013-biospectrum-asia-pacific-emerging-company-of-the-year/
queensland government http://statements.qld.gov.au/statement/2017/3/27/qlds-largest-startup-hub-to-drive-innovation-and-generate-jobs

Zdjęcia

Zdjęcia 33
Zdjęcia bez atrybutu ALT 0
Zdjęcia bez atrybutu TITLE 6
Korzystanie Obraz ALT i TITLE atrybutu dla każdego obrazu.

Zdjęcia bez atrybutu TITLE

/images/default-source/oneventures_2.0/springboard_logo_120x56.jpg?sfvrsn=0
/images/default-source/oneventures_2.0/heads-over-heels_logo_90x56.jpg?sfvrsn=0
/images/default-source/oneventures_2.0/ilab_logo_80x56.jpg?sfvrsn=0
/images/portfolio-images/linkedin-monochrome.jpg?sfvrsn=0
/images/default-source/oneventures_2.0/team_wlewin_201609_203x237.jpg?sfvrsn=0
/images/default-source/oneventures_2.0/team_rmgreene_201609_203x237.jpg?sfvrsn=0

Zdjęcia bez atrybutu ALT

empty

Ranking:


Alexa Traffic
Daily Global Rank Trend
Daily Reach (Percent)









Majestic SEO











Text on page:

about us team funds portfolio awards news contact us about us team funds portfolio awards news contact us investment with purpose oneventures builds great businesses working alongside driven and ambitious management teams, contributing venture capital and strong operational and executional team skills. the companies and the individuals we back are commercialising products and services that tackle large global market needs and seeking to accelerate their international growth and development. oneventures invests australia wide and is based in sydney with offices in melbourne and brisbane. our companies operate in global markets with offices in san francisco, palo alto, new jersey, boston, los angeles, manilla, ho chi minh city and london. the firm has $320m in funds under management across 3 funds and 8 co-investment funds. fund ii and iii are open for applications from technology and healthcare businesses. a global growth investment focus drives investment selection and fund creation. oneventures portfolio includes companies with truly disruptive and innovative products tackling multi-$billion problems from healthcare: needle free vaccine delivery, dementia patient care and allergy treatment; though to the connected world: hr management in the cloud, personalised learning and virtual communications. proudly supporting connect with us about oneventures established as an early stage investment business in 2007, the firm moved into venture capital in late 2008 and launched the only vc fund in australia in 2010 post the global financial crisis. the team has a stellar track record in building high growth companies in international markets. a unique blend of entrepreneurs, technology business founders and business executives combined with software, applied sciences and medical domain depth. we apply this expertise to mentor and collaborate with founders, ceos and company management and provide leadership on the boards of our investee companies. our investors work with us to support our companies by providing strategic advice and access to networks. they trust us to deliver results and provide a high level of accountability and transparency. we have an extensive investor network of high net worth investors and family offices representing approximately $20b in net worth. exit value created for investors delivered by members of the investment team is approximately $1.5b including 4 nasdaq companies. we focus on bringing innovative products to global markets and hold ourselves and our companies to high standards of performance. we ensure our companies are adequately capitalised to allow management to achieve significant commercial milestones and ultimately deliver financial returns to the business owners and our investors. we partner with some of the largest and best known global investors and corporations. afsl oneventures management pty ltd is a designate under oneventures nominees pty ltd's afsl (licence no: 462825) issued by the australian securities and investments commissions, authorising the manager to provide such financial services as the manager provides during the course of its duties as manager of the fund. the oneventures team all partners have many years of c-level, board and investment experience. coupled with this is a track record of identifying investment opportunities in global markets with strong international business backgrounds and networks. the oneventures investment team has 7 technology related higher degrees. dr michelle deaker managing partner dr paul kelly managing partner anne-marie birkill managing partner graeme wald principal dr amir zalcenstein investment manager, healthcare james mcgrath investment analyst helen liu chief financial officer jelly jakob accounts jen ball office manager member name title board of directors walter lewin oneventures board of directors simon moore oneventures board of directors roger massy-greene oneventures board of directors funds oneventures has three funds, two of which are actively investing. the oneventures innovation and growth fund ii and oneventures healthcare fund iii, have approximately $200m in available capital and are currently seeking investment opportunities in technology and healthcare businesses. all three of our main funds are early stage venture capital limited partnerships (esvclps) providing investors tax benefits for their vc asset class investing. we also raise additional capital alongside our funds from our limited partners as our investments mature, providing companies with the potential for larger rounds of financing and co-investment opportunities. this allow investors to improve their returns and back their favoured companies further. recent larger raises have included rounds of up to $30m. oneventures is currently looking for truly transformative companies to join its portfolio of innovative companies. if you think your company has what it takes, read the application for funding page and submit your application now. oneventures healthcare fund iii oneventures recently launched its $170m healthcare fund iii, which is focused on investing in companies with products that have reached clinical proof of concept, with at least phase 1 or equivalent trial results; a clear commercial, regulatory and reimbursement pathway; and well defined value inflection and exit points on deal entry. the oneventures' team has deep experience in driving opportunities through the fda regulatory process and commercialising biomedical innovations in global markets. the fund launched in december 2016 and is licenced under the commonwealth government’s biomedical translation fund (btf) programme. the btf programme was established to provide a pool of public and private funds for investment in promising biomedical innovations with commercialisation potential managed by leading australian venture firms. oneventures was granted an $85 million license supported by matching capital from its private investor network. the government funding provides benefits to investors both during the investment phase and on realisation. the fund will invest $10 to $20 million in australian domiciled companies commercialising medical devices, drugs in clinical development or diagnostics. innovation and growth fund fund ii the oneventures innovation and growth fund ii was launched in october 2014 with $100m in available funds for technology and healthcare businesses. the fund is focused on later stage companies seeking growth and development capital for offshore expansion and market growth. fund ii is screening currently for technology companies with a strong product market fit and a clear path to revenue of $3 to 5m over the next 12 months. in particular, we are looking at investment opportunities where the experience of the oneventures management team can be leveraged to accelerate value creation and company success. the fund looks to invest on average $3 to 5m into any one company although rounds of up to $10m+ are also possible. oneventures innovation fund (fund i) the oneventures innovation fund is a $40m venture capital fund established to provide capital and expertise into early stage (seed and series a companies). this fund was launched in 2010 with the commonwealth government committing $20m from its innovation investment fund programme. capital from this fund is fully deployed. investment portfolio oneventures innovation fund (fund i) oneventures innovation and growth fund (fund ii) other investments awards and accolades oneventures innovation fund (fund i) other investments smart sparrow september 30, 2014 finalist in the bill and melinda gates foundation $20m digital courseware challenge vaxxas august 26, 2014 world economic forum technology pioneer 2015 incoming media may 29, 2014 warner bros announces 2014 media camp class incoming media july 15, 2013 spiffy award nominee 2013 - ground breaking award for engineering smart sparrow may 2, 2013 global impact learning awards 2013 (silver) vaxxas march 18, 2013 biospectrum emerging company of the year 2012 see all awards latest news qld’s largest startup hub to drive innovation and generate jobs by oneventures administrator | mar 28, 2017 ​date: 27 march 2017 source: queensland government full story qld’s largest startup hub to drive innovation and generate jobs mar 28, 2017 full story find-me technologies strengthens the board in readiness for rapid growth feb 20, 2017 full story oneventures awarded biomedical translation $170m funding dec 14, 2016 full story data published in cancer medicine demostrate clinical genomics' blood test for colorectal cancer recurrence is two-fold more sensitive than cea test oct 19, 2016 full story clinical genomics strenghtens it's leadership team with multiple key appointments oct 19, 2016 full story see all news contact us for entrepreneurs we are now screening companies for oneventures fund ii which is a series a and beyond growth fund focusing on the technology sector. to qualify for funding, your company should meet the following criteria: australian domiciled company we invest in technology companies from many sectors, but we are particularly interested in companies from the following sectors: healthcare, education, mobile, media, cloud computing and data, security and privacy, machine learning, software, sensors and robotics or food security if a life sciences company, your product should have a strong proof of concept and be at a minimum, in a late stage clinical trial and/or well progressed through the regulatory process if from another sector, your company should be generating sustainable revenue and have a strong market validation approaching profitability with capital required to fuel growth and global expansion if you meet the above criteria, send us a brief document (a 2-page executive summary or introductory powerpoint is sufficient, please do not send larger documents or full information memorandums at this stage) covering at a minimum the following points to entrepreneurs@one-ventures.com: summarize in 2 sentences what your company does (this is important) identify the market, value proposition and your competitive advantage tell us about your progress to date state your revenue for the last financial year and projected revenue for current financial year indicate capital required and how it will be used include 3 point bios of each executive and contact details we will review your proposal and endeavour to revert to you within 2 weeks. for investors investor enquiries: investors@one-ventures.com general enquiries back to the top general enquiries: admin@one-ventures.com telephone: +61 2 8205 7379facsimile: +61 2 9247 9181 //--> sydney oneventures pty ltd level 13 179 elizabeth street sydney nsw 2000 australia brisbane the precinct level 2, 315 brunswick st fortitude valley qld 4006 australia melbourne c/o fb rice level 14, 90 collins street melbourne vic 3000 australia © 2015 oneventures pty ltd one vision, one team, one purpose disclaimer|contact us


Here you find all texts from your page as Google (googlebot) and others search engines seen it.

Words density analysis:

Numbers of all words: 1631

One word

Two words phrases

Three words phrases

and - 4.9% (80)
the - 3.8% (62)
fund - 2.88% (47)
invest - 2.64% (43)
one - 2.51% (41)
venture - 2.39% (39)
oneventures - 1.9% (31)
our - 1.84% (30)
for - 1.47% (24)
are - 1.47% (24)
investment - 1.35% (22)
with - 1.29% (21)
companies - 1.29% (21)
mar - 1.16% (19)
you - 0.8% (13)
any - 0.8% (13)
capital - 0.8% (13)
investor - 0.8% (13)
innovation - 0.8% (13)
growth - 0.74% (12)
team - 0.74% (12)
funds - 0.67% (11)
market - 0.61% (10)
global - 0.61% (10)
investors - 0.61% (10)
your - 0.61% (10)
care - 0.61% (10)
all - 0.61% (10)
company - 0.61% (10)
technology - 0.55% (9)
australia - 0.55% (9)
healthcare - 0.55% (9)
from - 0.55% (9)
business - 0.55% (9)
award - 0.49% (8)
has - 0.49% (8)
full - 0.49% (8)
its - 0.43% (7)
have - 0.43% (7)
this - 0.43% (7)
provide - 0.43% (7)
board - 0.43% (7)
partner - 0.43% (7)
management - 0.43% (7)
large - 0.43% (7)
financial - 0.37% (6)
see - 0.37% (6)
two - 0.37% (6)
stage - 0.37% (6)
medical - 0.37% (6)
story - 0.37% (6)
over - 0.37% (6)
product - 0.37% (6)
commercial - 0.37% (6)
chi - 0.37% (6)
net - 0.37% (6)
work - 0.37% (6)
point - 0.31% (5)
contact - 0.31% (5)
manager - 0.31% (5)
level - 0.31% (5)
opportunities - 0.31% (5)
office - 0.31% (5)
strong - 0.31% (5)
awards - 0.31% (5)
portfolio - 0.31% (5)
high - 0.31% (5)
under - 0.31% (5)
vic - 0.31% (5)
focus - 0.31% (5)
markets - 0.31% (5)
late - 0.31% (5)
$20 - 0.31% (5)
clinical - 0.31% (5)
launched - 0.31% (5)
2013 - 0.31% (5)
2014 - 0.31% (5)
new - 0.31% (5)
can - 0.25% (4)
investments - 0.25% (4)
funding - 0.25% (4)
fit - 0.25% (4)
revenue - 0.25% (4)
ltd - 0.25% (4)
pty - 0.25% (4)
australian - 0.25% (4)
(fund - 0.25% (4)
current - 0.25% (4)
media - 0.25% (4)
government - 0.25% (4)
was - 0.25% (4)
2016 - 0.25% (4)
directors - 0.25% (4)
2017 - 0.25% (4)
biomedical - 0.25% (4)
drive - 0.25% (4)
rounds - 0.25% (4)
year - 0.25% (4)
about - 0.25% (4)
iii - 0.25% (4)
products - 0.25% (4)
news - 0.25% (4)
deliver - 0.25% (4)
their - 0.25% (4)
network - 0.25% (4)
businesses - 0.25% (4)
value - 0.25% (4)
back - 0.25% (4)
development - 0.18% (3)
should - 0.18% (3)
innovative - 0.18% (3)
larger - 0.18% (3)
$10 - 0.18% (3)
following - 0.18% (3)
established - 0.18% (3)
will - 0.18% (3)
oct - 0.18% (3)
now - 0.18% (3)
entrepreneurs - 0.18% (3)
application - 0.18% (3)
currently - 0.18% (3)
test - 0.18% (3)
investing - 0.18% (3)
into - 0.18% (3)
programme - 0.18% (3)
regulatory - 0.18% (3)
experience - 0.18% (3)
early - 0.18% (3)
learning - 0.18% (3)
executive - 0.18% (3)
businesses. - 0.18% (3)
companies. - 0.18% (3)
qld - 0.18% (3)
largest - 0.18% (3)
other - 0.18% (3)
approximately - 0.18% (3)
enquiries - 0.18% (3)
international - 0.18% (3)
sydney - 0.18% (3)
offices - 0.18% (3)
partners - 0.18% (3)
support - 0.18% (3)
providing - 0.18% (3)
managing - 0.18% (3)
melbourne - 0.18% (3)
seeking - 0.18% (3)
which - 0.18% (3)
include - 0.18% (3)
firm - 0.18% (3)
commercialising - 0.18% (3)
used - 0.18% (3)
qld’s - 0.12% (2)
services - 0.12% (2)
startup - 0.12% (2)
nominee - 0.12% (2)
hub - 0.12% (2)
incoming - 0.12% (2)
that - 0.12% (2)
ground - 0.12% (2)
generate - 0.12% (2)
accelerate - 0.12% (2)
2015 - 0.12% (2)
jobs - 0.12% (2)
may - 0.12% (2)
march - 0.12% (2)
allow - 0.12% (2)
28, - 0.12% (2)
not - 0.12% (2)
brisbane - 0.12% (2)
nsw - 0.12% (2)
street - 0.12% (2)
+61 - 0.12% (2)
general - 0.12% (2)
enquiries: - 0.12% (2)
each - 0.12% (2)
bios - 0.12% (2)
purpose - 0.12% (2)
date - 0.12% (2)
progress - 0.12% (2)
tell - 0.12% (2)
identify - 0.12% (2)
minimum - 0.12% (2)
document - 0.12% (2)
alongside - 0.12% (2)
send - 0.12% (2)
required - 0.12% (2)
concept - 0.12% (2)
security - 0.12% (2)
cloud - 0.12% (2)
but - 0.12% (2)
meet - 0.12% (2)
genomics - 0.12% (2)
19, - 0.12% (2)
vaxxas - 0.12% (2)
cancer - 0.12% (2)
data - 0.12% (2)
14, - 0.12% (2)
dec - 0.12% (2)
world - 0.12% (2)
expansion - 0.12% (2)
bill - 0.12% (2)
investing. - 0.12% (2)
looking - 0.12% (2)
recent - 0.12% (2)
markets. - 0.12% (2)
potential - 0.12% (2)
raise - 0.12% (2)
also - 0.12% (2)
class - 0.12% (2)
founders - 0.12% (2)
limited - 0.12% (2)
main - 0.12% (2)
available - 0.12% (2)
iii, - 0.12% (2)
software, - 0.12% (2)
sciences - 0.12% (2)
track - 0.12% (2)
three - 0.12% (2)
expertise - 0.12% (2)
member - 0.12% (2)
leadership - 0.12% (2)
many - 0.12% (2)
networks. - 0.12% (2)
course - 0.12% (2)
during - 0.12% (2)
provides - 0.12% (2)
results - 0.12% (2)
worth - 0.12% (2)
afsl - 0.12% (2)
exit - 0.12% (2)
returns - 0.12% (2)
record - 0.12% (2)
what - 0.12% (2)
sparrow - 0.12% (2)
programme. - 0.12% (2)
smart - 0.12% (2)
$20m - 0.12% (2)
series - 0.12% (2)
creation - 0.12% (2)
co-investment - 0.12% (2)
path - 0.12% (2)
screening - 0.12% (2)
truly - 0.12% (2)
domiciled - 0.12% (2)
though - 0.12% (2)
million - 0.12% (2)
private - 0.12% (2)
connect - 0.12% (2)
btf - 0.12% (2)
translation - 0.12% (2)
read - 0.12% (2)
commonwealth - 0.12% (2)
innovations - 0.12% (2)
process - 0.12% (2)
through - 0.12% (2)
points - 0.12% (2)
well - 0.12% (2)
clear - 0.12% (2)
trial - 0.12% (2)
phase - 0.12% (2)
proof - 0.12% (2)
focused - 0.12% (2)
$170m - 0.12% (2)
page - 0.12% (2)
2010 - 0.12% (2)
benefits - 0.12% (2)
fund ii - 0.61% (10)
oneventures innovation - 0.43% (7)
the oneventures - 0.43% (7)
innovation and - 0.37% (6)
full story - 0.37% (6)
growth fund - 0.31% (5)
the fund - 0.31% (5)
of the - 0.31% (5)
and growth - 0.25% (4)
have a - 0.25% (4)
fund (fund - 0.25% (4)
companies with - 0.25% (4)
innovation fund - 0.25% (4)
board of - 0.25% (4)
investment opportunities - 0.25% (4)
venture capital - 0.25% (4)
pty ltd - 0.25% (4)
our companies - 0.25% (4)
contact us - 0.25% (4)
global markets - 0.25% (4)
your company - 0.25% (4)
(fund i) - 0.18% (3)
us about - 0.18% (3)
rounds of - 0.18% (3)
managing partner - 0.18% (3)
capital and - 0.18% (3)
in global - 0.18% (3)
fund iii - 0.18% (3)
growth and - 0.18% (3)
to provide - 0.18% (3)
news contact - 0.18% (3)
and be - 0.18% (3)
fund is - 0.18% (3)
to the - 0.18% (3)
and healthcare - 0.18% (3)
2016 full - 0.18% (3)
early stage - 0.18% (3)
we are - 0.18% (3)
launched in - 0.18% (3)
other investments - 0.12% (2)
was launched - 0.12% (2)
general enquiries - 0.12% (2)
for technology - 0.12% (2)
investment fund - 0.12% (2)
technology companies - 0.12% (2)
series a - 0.12% (2)
with a - 0.12% (2)
to invest - 0.12% (2)
financial year - 0.12% (2)
largest startup - 0.12% (2)
smart sparrow - 0.12% (2)
2017 full - 0.12% (2)
in companies - 0.12% (2)
australian domiciled - 0.12% (2)
meet the - 0.12% (2)
company should - 0.12% (2)
oct 19, - 0.12% (2)
clinical genomics - 0.12% (2)
19, 2016 - 0.12% (2)
regulatory process - 0.12% (2)
see all - 0.12% (2)
28, 2017 - 0.12% (2)
and generate - 0.12% (2)
drive innovation - 0.12% (2)
hub to - 0.12% (2)
of concept - 0.12% (2)
capital required - 0.12% (2)
for the - 0.12% (2)
about us - 0.12% (2)
for funding - 0.12% (2)
from its - 0.12% (2)
the firm - 0.12% (2)
and our - 0.12% (2)
the investment - 0.12% (2)
for investors - 0.12% (2)
and provide - 0.12% (2)
with us - 0.12% (2)
on the - 0.12% (2)
and company - 0.12% (2)
in the - 0.12% (2)
investors and - 0.12% (2)
innovative products - 0.12% (2)
businesses. a - 0.12% (2)
with offices - 0.12% (2)
to accelerate - 0.12% (2)
awards news - 0.12% (2)
funds portfolio - 0.12% (2)
us team - 0.12% (2)
portfolio awards - 0.12% (2)
companies to - 0.12% (2)
oneventures management - 0.12% (2)
biomedical innovations - 0.12% (2)
team funds - 0.12% (2)
provide a - 0.12% (2)
established to - 0.12% (2)
the commonwealth - 0.12% (2)
and is - 0.12% (2)
through the - 0.12% (2)
focused on - 0.12% (2)
which is - 0.12% (2)
if you - 0.12% (2)
during the - 0.12% (2)
in technology - 0.12% (2)
fund iii, - 0.12% (2)
oneventures healthcare - 0.12% (2)
ii and - 0.12% (2)
investment team - 0.12% (2)
markets with - 0.12% (2)
track record - 0.12% (2)
and investment - 0.12% (2)
oneventures pty - 0.12% (2)
innovation and growth - 0.25% (4)
and growth fund - 0.25% (4)
oneventures innovation fund - 0.25% (4)
innovation fund (fund - 0.18% (3)
2016 full story - 0.18% (3)
and healthcare businesses. - 0.18% (3)
fund (fund i) - 0.18% (3)
news contact us - 0.18% (3)
in global markets - 0.18% (3)
your company should - 0.12% (2)
to drive innovation - 0.12% (2)
have a strong - 0.12% (2)
proof of concept - 0.12% (2)
drive innovation and - 0.12% (2)
startup hub to - 0.12% (2)
and generate jobs - 0.12% (2)
oct 19, 2016 - 0.12% (2)
about us team - 0.12% (2)
largest startup hub - 0.12% (2)
funds portfolio awards - 0.12% (2)
the commonwealth government - 0.12% (2)
established to provide - 0.12% (2)
healthcare fund iii, - 0.12% (2)
oneventures healthcare fund - 0.12% (2)
fund ii and - 0.12% (2)
healthcare businesses. a - 0.12% (2)
with offices in - 0.12% (2)
oneventures pty ltd - 0.12% (2)

Here you can find chart of all your popular one, two and three word phrases. Google and others search engines means your page is about words you use frequently.

Copyright © 2015-2016 hupso.pl. All rights reserved. FB | +G | Twitter

Hupso.pl jest serwisem internetowym, w którym jednym kliknieciem możesz szybko i łatwo sprawdź stronę www pod kątem SEO. Oferujemy darmowe pozycjonowanie stron internetowych oraz wycena domen i stron internetowych. Prowadzimy ranking polskich stron internetowych oraz ranking stron alexa.